Research Progress on 18F-Labeled Agents for Imaging of Myocardial Perfusion with Positron Emission Tomography.
Molecules
; 22(4)2017 Mar 30.
Article
em En
| MEDLINE
| ID: mdl-28358340
ABSTRACT
Coronary artery disease (CAD) is the leading cause of death in the world. Myocardial perfusion imaging (MPI) plays a significant role in non-invasive diagnosis and prognosis of CAD. However, neither single-photon emission computed tomography nor positron emission tomography clinical MPI agents can absolutely satisfy the demands of clinical practice. In the past decades, tremendous developments happened in the field of 18F-labeled MPI tracers. This review summarizes the current state of 18F-labeled MPI tracers, basic research data of those tracers, and the future direction of MPI tracer research.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doença da Artéria Coronariana
/
Radioisótopos de Flúor
/
Compostos Radiofarmacêuticos
/
Tomografia por Emissão de Pósitrons
/
Imagem de Perfusão do Miocárdio
Limite:
Humans
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article